D Arillotta, G Floresta, GD Papanti Pelletier, A Guirguis… - Brain Sciences, 2024 - mdpi.com
Glucagon-like peptide-1 (GLP-1) is involved in a range of central and peripheral pathways related to appetitive behavior. Hence, this study explored the effects of glucagon-like peptide …
T Adair - The Lancet Regional Health–Europe, 2024 - thelancet.com
The increase in obesity prevalence has been a leading public health concern in many high- income countries in recent decades. Obesity has been widely found to increase the risk of …
Semaglutide is a potent GLP-1 receptor agonist used in the treatment of type 2 diabetes mellitus due to its ability to regulate blood glucose levels and promote weight loss. On July …
Drug-target binding is a crucial parameter in drug discovery and design, ensuring drug efficacy and specificity. Semaglutide, a potent GLP-1 receptor agonist, is widely used to treat …
The advancement of computational drug discovery and design necessitates continuous innovation to enhance the accuracy and scope of predictive models for early-stage drug …